Variant report

Variant	nsv1063901
Chromosome Location	chr16:77640970-77688406
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:29)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:29 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:77678330..77681247-chr16:77683040..77686814,3	K562	blood:
2	chr16:77657528..77659608-chr16:77662783..77664358,2	MCF-7	breast:
3	chr16:77635547..77639833-chr16:77643081..77646196,4	MCF-7	breast:
4	chr16:77634214..77636366-chr16:77646332..77647931,2	MCF-7	breast:
5	chr16:77650374..77650964-chr3:174717215..174717905,2	MCF-7	breast:
6	chr16:77657528..77659608-chr16:77662783..77664358,2	MCF-7	breast:
7	chr16:77675283..77677201-chr16:77679287..77681153,2	MCF-7	breast:
8	chr16:77675283..77677201-chr16:77679287..77681153,2	MCF-7	breast:
9	chr16:77627298..77629189-chr16:77688223..77690020,2	MCF-7	breast:
10	chr16:77686332..77688882-chr16:77693068..77695679,2	MCF-7	breast:
11	chr16:77632750..77638052-chr16:77677805..77683228,7	MCF-7	breast:
12	chr16:77687539..77690141-chr16:78086576..78089013,2	MCF-7	breast:
13	chr16:77666135..77671025-chr16:77671164..77674266,4	K562	blood:
14	chr16:77678330..77681247-chr16:77683040..77686814,3	K562	blood:
15	chr16:77667748..77670064-chr16:77674734..77677404,2	MCF-7	breast:
16	chr16:77641802..77644551-chr16:77659308..77662282,2	MCF-7	breast:
17	chr16:77672608..77676304-chr16:77676785..77680142,3	MCF-7	breast:
18	chr16:77667748..77670064-chr16:77674734..77677404,2	MCF-7	breast:
19	chr16:77636436..77639856-chr16:77651156..77654256,4	MCF-7	breast:
20	chr16:77644345..77646917-chr16:77647534..77649296,2	MCF-7	breast:
21	chr16:77685342..77690368-chr16:77692022..77694160,4	MCF-7	breast:
22	chr16:77672608..77676304-chr16:77676785..77680142,3	MCF-7	breast:
23	chr16:77665200..77668006-chr16:77670083..77672540,2	MCF-7	breast:
24	chr16:77666135..77671025-chr16:77671164..77674266,4	K562	blood:
25	chr16:77641802..77644551-chr16:77659308..77662282,2	MCF-7	breast:
26	chr16:77652245..77655116-chr16:77670753..77672397,2	MCF-7	breast:
27	chr16:77644345..77646917-chr16:77647534..77649296,2	MCF-7	breast:
28	chr16:77652245..77655116-chr16:77670753..77672397,2	MCF-7	breast:
29	chr16:77665200..77668006-chr16:77670083..77672540,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NUDT7-2	chr16:77644434-77644578	ENSG00000261154.1

No data

Extended variants
information (count: 1111 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:1111 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185411840	chr16:77644456-77644457	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs172178	chr16:77644471-77644472	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs146674271	chr16:77644485-77644486	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs367994818	chr16:77644496-77644497	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs544752074	chr16:77644499-77644500	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs148399517	chr16:77644512-77644513	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs142492442	chr16:77644515-77644516	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
8	rs545947582	chr16:77644563-77644564	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
9	rs571731908	chr16:77645400-77645401	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs185730284	chr16:77645417-77645418	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs192329855	chr16:77645421-77645422	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs143222062	chr16:77645431-77645432	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs183648211	chr16:77645436-77645437	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs569429626	chr16:77645447-77645448	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs280871	chr16:77645461-77645462	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs573171587	chr16:77645475-77645476	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs188048371	chr16:77645479-77645480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs558685812	chr16:77645489-77645490	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs192274327	chr16:77645510-77645511	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs544021038	chr16:77645522-77645523	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs561026836	chr16:77645540-77645541	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs574381884	chr16:77645546-77645547	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs148377018	chr16:77645587-77645588	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs538079588	chr16:77645606-77645607	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs557684533	chr16:77645686-77645687	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs560471616	chr16:77645691-77645692	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs570897276	chr16:77645702-77645703	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs117157592	chr16:77645762-77645763	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs552413360	chr16:77645778-77645779	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs142204585	chr16:77645793-77645794	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs531531318	chr16:77645796-77645797	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs550836654	chr16:77645812-77645813	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs146379015	chr16:77645834-77645835	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs78260807	chr16:77645842-77645843	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs546553944	chr16:77645879-77645880	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs187075412	chr16:77645892-77645893	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs376572909	chr16:77645898-77645899	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs367808076	chr16:77645900-77645901	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs538898749	chr16:77645916-77645917	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs540429567	chr16:77645974-77645975	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs538080664	chr16:77646608-77646609	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs62046622	chr16:77646634-77646635	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs193302325	chr16:77646637-77646638	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs185526147	chr16:77646642-77646643	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs533829145	chr16:77646733-77646734	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs189598051	chr16:77646734-77646735	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs576954822	chr16:77646746-77646747	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs369579664	chr16:77646753-77646754	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs149879270	chr16:77646774-77646775	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs74026192	chr16:77646786-77646787	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Poland''s syndrome	22110015	CNVD
Neuroblastoma	21899760	CNVD
Liver carcinoma	19366792	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	19156837	CNVD
Acute myeloid leukemia	17377590	CNVD
Breast cancer	20409316	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Lung cancer	24585490	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:77645400-77646000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
2	chr16:77646600-77647400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr16:77647200-77647600	Enhancers	Fetal Muscle Leg	muscle
4	chr16:77651200-77653000	Enhancers	HUVEC	blood vessel
5	chr16:77651600-77652000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr16:77652000-77652200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr16:77652000-77652200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr16:77652000-77652200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
9	chr16:77665800-77666000	ZNF genes & repeats	Aorta	Aorta
10	chr16:77666000-77671400	Weak transcription	Aorta	Aorta
11	chr16:77667600-77673400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr16:77668800-77671600	Weak transcription	Fetal Heart	heart
13	chr16:77670400-77670600	Enhancers	Fetal Muscle Leg	muscle
14	chr16:77670600-77671600	Weak transcription	Fetal Muscle Leg	muscle
15	chr16:77671200-77672600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr16:77671400-77671600	Enhancers	Aorta	Aorta
17	chr16:77671600-77672000	Flanking Active TSS	Aorta	Aorta
18	chr16:77671600-77672600	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr16:77671600-77672600	Enhancers	Fetal Heart	heart
20	chr16:77671600-77672600	Enhancers	Fetal Lung	lung
21	chr16:77671600-77673000	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr16:77671600-77673000	Enhancers	Fetal Muscle Leg	muscle
23	chr16:77671800-77672200	Enhancers	Fetal Kidney	kidney
24	chr16:77671800-77672200	Enhancers	Skeletal Muscle Female	skeletal muscle
25	chr16:77671800-77672400	Enhancers	Fetal Stomach	stomach
26	chr16:77672000-77672200	Enhancers	Aorta	Aorta
27	chr16:77672000-77672600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr16:77672200-77672400	Flanking Active TSS	Aorta	Aorta
29	chr16:77672200-77672600	Active TSS	Fetal Brain Male	brain
30	chr16:77672400-77672800	Enhancers	Aorta	Aorta
31	chr16:77673400-77673600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr16:77676800-77677000	Enhancers	Fetal Lung	lung
33	chr16:77679200-77680600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr16:77679600-77679800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr16:77679800-77681800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr16:77680400-77682600	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr16:77680600-77681000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr16:77681000-77682600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr16:77681200-77682400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr16:77681800-77682200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr16:77682600-77683600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr16:77682600-77693800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
43	chr16:77683600-77689600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr16:77683800-77684000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr16:77684000-77684200	Enhancers	Adipose Nuclei	Adipose
46	chr16:77684200-77685400	Weak transcription	Adipose Nuclei	Adipose
47	chr16:77685400-77686600	Enhancers	Adipose Nuclei	Adipose
48	chr16:77685800-77686600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr16:77686200-77687000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr16:77686600-77687000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links